Peanut Allergy Immunotherapy Research Trial for Adults (Sydney)

RESEARCH OPPORTUNITY – Peanut Allergy Immunotherapy Research Trial for Adults (Sydney)

Are you an adult living with a severe peanut allergy? Do you have a child over the age of 16 with a severe peanut allergy?

St Vincent’s Hospital in Sydney is now recruiting for their peanut allergy immunotherapy research trial (OPAL study).

Peanut oral immunotherapy involves consuming small but increasing amounts of peanut over time to help build tolerance. The study is using an anti-allergy medication (omalizumab) together with peanut oral immunotherapy (also known as desensitisation), to understand whether peanut immunotherapy will be safer, quicker and more tolerable.

Please note all study visits will be conducted at St Vincent's Hospital in Sydney.

For more information and to register your interest please contact the St Vincent's Hospital team via email: This email address is being protected from spambots. You need JavaScript enabled to view it.

Acute Anaphylaxis CSS
Acute Anaphylaxis Clinical Care Standard - Learn more...
Atopic Dermatitis
allergy250K teens/young adults
Food allergy training

Our Supporters

Diamond


Viatris
Sanofi
Nestle
Allergy Concepts

Platinum


  • Bulla
  • NSW Food Authority
  • Novartis
  • Pfizer
  • Stallergenes Greer

Gold


  • dbv technologies
  • Mondelez
  • Nurticia
Silver

  • abbvie
  • Australian Camps Association
  • Bayer
  • Sanctuary Early Learning
  • Sweet William

© 2022 ALLERGY & ANAPHYLAXIS AUSTRALIA
ABN: 70 693 242 620

 


ALLERGY & ANAPHYLAXIS AUSTRALIA
is supported by funding from the
Australian Government,
Department of Health.


ALLERGY & ANAPHYLAXIS AUSTRALIA acknowledges and pays respect to the traditional custodians of the lands on which we work, live and play.

IN AN EMERGENCY

If you are having an allergic reaction follow advice on your ASCIA Action Plan.

If in doubt, give the Anapen® or EpiPen®.

Do not call us for emergency advice.

If you do not have an ASCIA Action Plan and/or an Anapen® or EpiPen® call triple zero (000) for an ambulance.